Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [12782]

ASCO 2019: International clinical trial of new drug for men with advanced prostate cancer yields strong result

ASCO 2019: International clinical trial of new drug for men with advanced prostate cancer yields strong result

ASCO 2019: Immunotherapy better than aggressive chemotherapy as first treatment option for recurrent head and neck cancer

ASCO 2019: Immunotherapy better than aggressive chemotherapy as first treatment option for recurrent head and neck...

ASCO 2019: NRG trial suggests total neoadjuvant therapy for locally advanced rectal cancer is safe

ASCO 2019: NRG trial suggests total neoadjuvant therapy for locally advanced rectal cancer is safe

ASCO 2019: NRG oncology trial of metformin for non-small cell lung cancer

ASCO 2019: NRG oncology trial of metformin for non-small cell lung cancer

ASCO 2019: Novel targeted-antibody treatment produced responses in nearly half of patients with advanced urothelial cancer

ASCO 2019: Novel targeted-antibody treatment produced responses in nearly half of patients with advanced...

ASCO 2019: Colorectal cancer patients with liver metastases live just as long after laparoscopic surgery as open surgery

ASCO 2019: Colorectal cancer patients with liver metastases live just as long after laparoscopic surgery as open...

ASCO 2019: Maintenance therapy with PARP inhibitor olaparib delays progression of BRCA-related pancreatic cancer

ASCO 2019: Maintenance therapy with PARP inhibitor olaparib delays progression of BRCA-related pancreatic cancer

ASCO 2019: New blood test predicts breast cancer’s return at start of treatment

ASCO 2019: New blood test predicts breast cancer’s return at start of treatment

ASCO 2019: Adding enzalutamide to standard first-line treatment improves survival for men with metastatic hormone-sensitive prostate cancer

ASCO 2019: Adding enzalutamide to standard first-line treatment improves survival for men with metastatic hormone...

ASCO 2019: Earlier ovarian cancer diagnoses and treatment seen after ACA implementation

ASCO 2019: Earlier ovarian cancer diagnoses and treatment seen after ACA implementation

More from ecancer